A report of 121 families with proven mutations. Clin Genet 2008,74(3):233–242.PubMedCrossRef 6. Vasen

HF, Abdirahman M, Brohet R, et al.: One to 2-year surveillance intervals reduce risk of colorectal cancer in families with lynch syndrome. Gastroenterology 2010,138(7):2300–2306.PubMedCrossRef 7. Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, et al.: Ten years after mutation testing for lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009,27(28):4793–4797.PubMedCrossRef 8. Lynch HT, Lynch PM, Lanspa SJ, et al.: Review of the lynch syndrome: history, molecular selleck compound genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 2009,76(1):1–18.PubMedCentralPubMedCrossRef

9. Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261–268.PubMedCentralPubMedCrossRef 10. Meyer JE, Narang T, Schnoll-Sussman FH, et al.: Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer 2010, 116:4354–4359.PubMedCentralPubMedCrossRef 11. O’Connell JB, Maggard MA, Liu JH, et al.: Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003, 69:866–872.PubMed 12. Siegel RL, Jemal A, Ward selleckchem EM: Increase incidence of colorectal

cancer among young men and women in the United States. Cancer Epidemiol Biomatkers Prev 2009, 18:1695–1698.CrossRef 13. Chang DT, Pai RK, Rybicki LA, et al.: Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol 2012, 25:1128–1139.PubMedCrossRef 14. Mills SE, Allen MS Jr: Colorectal carcinoma Astemizole in the first three decades of life. Am J Surg Pathol 1979, 3:443–448.PubMedCrossRef 15. Minardi AJ Jr, Sittig KM, Zibari GB, et al.: Colorectal cancer in the young patient. Am Surg 1998, 64:849–853.PubMed 16. Parramore JB, Wei JP, Yeh KA: Colorectal cancer in patients under forty: presentation and outcome. Am Surg 1998, 64:563–567.PubMed 17. Smith C, Butler JA: Colorectal cancer in patients younger than 40 years of age. Dis Colon Rectum 1989, 32:843–846.PubMedCrossRef 18. Yantiss RK, Goodarzi M, Zhou XK, et al.: SHP099 datasheet Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 2009, 33:572–582.PubMedCrossRef 19. Antelo M, Balaguer F, Shia J, et al.: A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS One 2012,7(9):e45357.PubMedCentralPubMedCrossRef 20. Jasperson KW, Vu TM, Schwab AL, et al.